20.09.2019 05:19:30
OMX NORDIC SUP/HEALTH CARE(TR)
3246.67
EUR
25.0122
0.78%
19.09.2019 17:35
 
Chart
Kursdaten
Kurs - Eröffnung -
Diff. absolut - Tages-Hoch -
Diff. % - Tages-Tief -
Volumen - Umsatz -
Schlusskurs vom 18.09.2019 3221.66 Volatilität in % -
Börse Letzter Handel 19.09.2019 / 17:35
Währung EUR Aktualisierungsstand 20.09.2019 / 05:19
Kursentwicklung (berechnet mit Vortageskurs)
Zeitraum Perf. Hoch Tief
2019 15.95% 3343.0 2787.5
1 Woche 1.38% 3253.2 3154.7
1 Monat 0.18% 3343.0 3100.1
3 Monate -0.29% 3343.0 3091.2
6 Monate 1.10% 3343.0 3021.8
1 Jahr 6.48% 3343.0 2698.2
3 Jahre 28.33% 3343.0 2087.2
21.86
13
0.39
SMI
15.95
19.4
SMI
-10.68
SMI
2017
2018
2019
{"2017":{"performance":21.86,"chartHeight":22.955557816379,"year":2017,"ID_NOTATION":"57305643"},"2018":{"performance":0.39,"chartHeight":7.8706404684554,"year":2018,"ID_NOTATION":"57305643"},"2019":{"performance":15.95,"chartHeight":21.414135727679,"year":2019,"ID_NOTATION":"57305643"}}
{"2017":{"performance":13,"chartHeight":20.414022264304,"year":2017,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"},"2018":{"performance":-10.68,"chartHeight":19.452703326535,"year":2018,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"},"2019":{"performance":19.4,"chartHeight":22.371726849929,"year":2019,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"}}
{"2017":{"performance":6.87,"chartHeight":17.29505857536,"year":2017,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"},"2018":{"performance":-14.4,"chartHeight":20.914196917042,"year":2018,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"},"2019":{"performance":18.37,"chartHeight":22.104940396128,"year":2019,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"}}
{"2017":{"performance":24.39,"chartHeight":23.491118122915,"year":2017,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"},"2018":{"performance":-5.97,"chartHeight":16.608375900852,"year":2018,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"},"2019":{"performance":16.37,"chartHeight":21.541242364929,"year":2019,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"}}
{"2017":{"performance":17.9,"chartHeight":21.978192588699,"year":2017,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"},"2018":{"performance":-13.82,"chartHeight":20.713149735591,"year":2018,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"},"2019":{"performance":10.14,"chartHeight":19.198970714795,"year":2019,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"}}
{"2017":{"performance":13.05,"chartHeight":20.432795046975,"year":2017,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"},"2018":{"performance":-18.13,"chartHeight":22.040628623724,"year":2018,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"},"2019":{"performance":17.98,"chartHeight":22,"year":2019,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"}}
Einzelwerte *(Kursentwicklung in % berechnet mit Vortageskurs) Autoupdate 20.09.2019 05:19:30
Titel
Kurs
+/-%
+/-
Volumen Total
Open
Low
High
Volumen Geld
Geld
Brief
Volumen Brief
*+/- in % 1 Wo.
*+/- in % 2019
ADDLIFE AB B - - - - - - - - - - - - -
ALK-Abell B - - - - - - - - - - - - -
ALLIGATOR BIOSC. AB - - - - - - - - - - - - -
ARJO AB B - - - - - - - - - - - - -
ASCELIA PHARMA AB - - - - - - - - - - - - -
ATTENDO AB - - - - - - - - - - - - -
Active Biotech - - - - - - - - - - - - -
Ambea AB - - - - - - - - - - - - -
Ambu - - - - - - - - - - - - -
AstraZeneca - - - - - - - - - - - - -
BACTIGUARD HLDG B - - - - - - - - - - - - -
BIOARCTIC AB B - - - - - - - - - - - - -
BONESUPPORT HOLDING - - - - - - - - - - - - -
Bavarian Nordic - - - - - - - - - - - - -
BioGaia B - - - - - - - - - - - - -
Biohit B - - - - - - - - - - - - -
Bioinvent Internat - - - - - - - - - - - - -
Bioporto A/S - - - - - - - - - - - - -
Biotage - - - - - - - - - - - - -
Boule Diagnostics - - - - - - - - - - - - -
C-RAD B - - - - - - - - - - - - -
CALLIDITAS THERAPEUT - - - - - - - - - - - - -
CAMURUS AB - - - - - - - - - - - - -
CHRISTIAN HANSEN - - - - - - - - - - - - -
COLOPLAST - - - - - - - - - - - - -
Cantargia AB - - - - - - - - - - - - -
Cellavision - - - - - - - - - - - - -
Chemometec - - - - - - - - - - - - -
Dedicare B - - - - - - - - - - - - -
Elekta B - - - - - - - - - - - - -
Elos Medtech ser. B - - - - - - - - - - - - -
Episurf Medical B - - - - - - - - - - - - -
Feelgood Svenska - - - - - - - - - - - - -
GETINGE - - - - - - - - - - - - -
GHP Specialty Care - - - - - - - - - - - - -
GN Store Nord - - - - - - - - - - - - -
Genmab - - - - - - - - - - - - -
H. Lundbeck - - - - - - - - - - - - -
HANDICARE GROUP AB - - - - - - - - - - - - -
HUMANA AB - - - - - - - - - - - - -
Hansa Biopharma - - - - - - - - - - - - -
IMMUNOVIA AB - - - - - - - - - - - - -
INFANT BACT.THER.B S - - - - - - - - - - - - -
Immunicum - - - - - - - - - - - - -
Karo Pharma - - - - - - - - - - - - -
Karolinska Devel B - - - - - - - - - - - - -
MEDICOVER AB - - - - - - - - - - - - -
MedCap - - - - - - - - - - - - -
Medivir B - - - - - - - - - - - - -
Moberg Pharma - - - - - - - - - - - - -
NOVOZYMES - - - - - - - - - - - - -
NeuroVive Pharma - - - - - - - - - - - - -
Neurosearch - - - - - - - - - - - - -
Novo-Nordisk B - - - - - - - - - - - - -
OEssur - - - - - - - - - - - - -
ONCOPEPTIDES AB O.N. - - - - - - - - - - - - -
ONXEO - - - - - - - - - - - - -
ORPHAZYME A/S DK 1 - - - - - - - - - - - - -
Oasmia Pharma - - - - - - - - - - - - -
Orexo - - - - - - - - - - - - -
Oriola 'A' - - - - - - - - - - - - -
Oriola 'B' - - - - - - - - - - - - -
Orion A - - - - - - - - - - - - -
Orion B - - - - - - - - - - - - -
Ortivus A - - - - - - - - - - - - -
Ortivus B - - - - - - - - - - - - -
Pihlajalinna - - - - - - - - - - - - -
Probi Ab - - - - - - - - - - - - -
Q-LINEA AB - - - - - - - - - - - - -
Raysearch Lab B - - - - - - - - - - - - -
Recipharm - - - - - - - - - - - - -
Revenio Group - - - - - - - - - - - - -
SANIONA AB (PUBL) - - - - - - - - - - - - -
SILMAEASEMA OYJ - - - - - - - - - - - - -
Sectra B - - - - - - - - - - - - -
Swedish Orphan Bio - - - - - - - - - - - - -
Terveystalo - - - - - - - - - - - - -
VELOXIS PHARMA - - - - - - - - - - - - -
Vitrolife AB - - - - - - - - - - - - -
WILLIAM DEMANT - - - - - - - - - - - - -
Xvivo Perfusion - - - - - - - - - - - - -
Zealand Pharma - - - - - - - - - - - - -